Posters

Search Title by author or title

Cilio-choroidal melanoma: a case report

Poster Details

First Author: K.Madbouhi MOROCCO

Co Author(s):    B. Mrini   A. Redallah   F. Boudguigue   Y. Boubnane   O. Charkaoui        

Abstract Details

Purpose:

Uveal melanoma is a malignant tumor that affects the iris, the ciliary body, and the choroid. It is relatively rare and the most common primary malignant intraocular tumor in adults. It is an aggressive tumor that gives metastatic spread in about 50% of cases. The aim of our work is to study the clinical and radiological characteristics of the tumor, and the therapeutic strategies through observation and review of the literature.

Setting:

Department of Ophthalmology A. Specialty Hospital of Rabat

Methods:

We report the case of a 60-year-old patient, operated for pterygium of the left eye, who cam in ophthalmology departement for amputation of the visual field of the left eye associated with phosphenes and intermittent pain. The clinical examination found visual acuity at 20/20 in OD and finger movement in OG. Eye tone at 14 mmhg on the right and 30 mmhg on the left. In biomicroscopy, we observed a dilation of the temporal episcleral vessels and a homogeneous brownish mass retrolental obstructing the visual axis.

Results:

Ocular ultrasound of the left eye shows a hyperhechogenic tumor process measuring 13 mm thick with evidence of choroidal excavation and satellite detachment of the retina. The CT scan shows the presence of a well-limited left intraocular hyperdense mass which increases after injection of PDC measuring 18mm by 13mm. The UBM has shown a cilio-choroidal location of the tumor. The tumor extension workup was normal. The patient underwent enucleation. An anatomopathological examination of the operative specimen was in favor of cilio-choroidal melanoma.

Conclusions:

Cilio-choroidal melanoma remains a serious disease that involves the visual prognosis of the affected eye and the vital prognosis. Early detection greatly improves the prognosis.

Financial Disclosure:

None

Back to Poster listing